Listen to the article
An Appleton medical clinic and its physician have agreed to a significant settlement with the federal government over improper Medicare billing practices, authorities announced this week.
Apple Medical Clinic and Dr. Michael Johnson have settled allegations of False Claims Act violations for $382,362.95, according to the U.S. Attorney’s Office for the Eastern District of Wisconsin. The settlement resolves claims that the Appleton-based clinic billed Medicare for treatments that were not medically necessary or eligible for reimbursement.
At the center of the dispute was the clinic’s use of a device called the RST Sanexas neoGEN-Series, which was marketed for pain management. According to federal prosecutors, the clinic offered outpatient pain blocking treatments using this device in conjunction with vitamin blend injections and other services, including epidermal nerve fiber density testing.
Federal authorities contend that Dr. Johnson advertised these treatments as Medicare-covered services despite knowing they did not meet the program’s criteria for medical necessity. The investigation revealed that Johnson himself was a distributor for the device, creating a potential conflict of interest in his recommendation and use of the equipment.
“The settlement highlights our commitment to protecting federal healthcare programs and ensuring that Medicare funds are used appropriately,” said a spokesperson from the U.S. Attorney’s Office, who declined to be named for this article.
The case represents part of a broader federal effort to crack down on improper billing practices in the healthcare industry. Medicare fraud costs taxpayers billions annually and diverts resources away from patients who genuinely need care.
Particularly troubling to investigators was Johnson’s alleged marketing of the Sanexas device for uses beyond its FDA clearance, potentially putting patients at risk. The U.S. Attorney’s Office noted that Johnson’s practices contradicted both National and Local Coverage Determinations, which set guidelines for appropriate Medicare reimbursement.
The settlement amount consists of a $175,000 direct payment plus the government’s retention of $207,362.95 that had been held by the Centers for Medicare and Medicaid Services (CMS). This resolution allows the government to recover funds without the expense and uncertainty of continued litigation.
Healthcare fraud experts note that cases like this have become increasingly common as medical practices face financial pressures and Medicare reimbursement rates tighten across many specialties.
“We’re seeing more scrutiny of alternative treatments and medical devices, particularly when there’s questionable evidence supporting their effectiveness for Medicare-covered conditions,” said Jane Reynolds, a healthcare compliance consultant not involved in this case. “Providers need to be extremely careful about what they bill to federal programs.”
The settlement comes amid heightened attention to Medicare spending, which reached approximately $800 billion in 2022. With an aging population and rising healthcare costs, federal authorities have intensified efforts to ensure funds are properly allocated.
For patients of Apple Medical Clinic, the settlement raises questions about the efficacy of treatments they may have received. While the agreement does not include any determination of liability, the allegations suggest some treatments may have been inappropriately recommended or administered.
Neither Dr. Johnson nor representatives from Apple Medical Clinic responded to requests for comment on the settlement.
The case was handled by the U.S. Attorney’s Office for the Eastern District of Wisconsin in coordination with the Department of Health and Human Services Office of Inspector General, which investigates potential fraud in federal healthcare programs.
For Medicare beneficiaries, the case serves as a reminder to question whether treatments offered by healthcare providers are actually covered by their insurance, particularly when they involve newer technologies or alternative approaches to pain management.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
16 Comments
It’s disheartening to see allegations of Medicare fraud, as it can erode public trust in the healthcare system. I hope this case serves as a wake-up call for the industry to prioritize ethical and transparent billing practices.
Absolutely. Restoring and maintaining public confidence in the healthcare system should be a top priority for both providers and regulators in the aftermath of such cases.
It’s concerning to see allegations of Medicare fraud in the medical industry. Patients deserve to have confidence that their treatments are medically necessary and appropriately billed. I hope this settlement serves as a deterrent to unethical billing practices.
Agreed. Maintaining integrity in medical billing is crucial for protecting patient trust and the sustainability of public healthcare programs like Medicare.
The alleged use of a device for unapproved, non-medically necessary treatments is quite concerning. I’m curious to learn more about the specifics of the device and how it was marketed to patients and Medicare.
That’s a good point. The details around the device’s intended use and marketing claims would be important to understand the full scope of this case.
This settlement highlights the need for stronger oversight and accountability measures in the medical industry, particularly when it comes to billing practices and the use of medical devices. Patients deserve to know their care is being delivered ethically and appropriately.
Well said. Enhancing regulatory oversight and enforcement, as well as promoting a culture of ethical practices, will be crucial in preventing similar cases of Medicare fraud from occurring in the future.
While the settlement amount is substantial, I wonder if it will truly deter similar fraudulent behavior in the future. Stronger penalties and more rigorous oversight may be needed to combat this issue effectively.
That’s a fair point. Ensuring meaningful deterrence likely requires a multi-pronged approach, including robust enforcement, significant penalties, and ongoing monitoring to prevent repeat offenses.
This case serves as a reminder of the importance of transparency and accountability in the medical industry. I hope it encourages other providers to closely review their own billing practices and ensure compliance.
Well said. Proactive self-auditing and a culture of ethical billing practices can go a long way in preventing future instances of Medicare fraud.
As a taxpayer, I’m glad to see the government take action against fraudulent Medicare billing practices. Protecting the integrity of public healthcare programs should be a top priority.
Agreed. Rooting out waste, fraud, and abuse in Medicare spending is crucial for ensuring the program’s sustainability and equitable access to care for all beneficiaries.
This case highlights the importance of oversight and enforcement when it comes to Medicare compliance. While the settlement amount is substantial, I hope it sends a strong message about the consequences of fraudulent billing practices.
Absolutely. Robust auditing and accountability measures are essential to uphold the integrity of the Medicare system and ensure patients receive the care they need.